Ellen M McDonagh

Ellen M McDonagh

UNVERIFIED PROFILE

Are you Ellen M McDonagh?   Register this Author

Register author
Ellen M McDonagh

Ellen M McDonagh

Publications by authors named "Ellen M McDonagh"

Are you Ellen M McDonagh?   Register this Author

19Publications

657Reads

10Profile Views

Single-base substitutions in the CHM promoter as a cause of choroideremia.

Hum Mutat 2017 06 24;38(6):704-715. Epub 2017 Mar 24.

Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.23212DOI Listing
June 2017

PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics.

Pharmacogenet Genomics 2017 01;27(1):39-42

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA dGenomics England, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140711PMC
January 2017

PharmGKB summary: isoniazid pathway, pharmacokinetics.

Pharmacogenet Genomics 2016 09;26(9):436-44

Departments of aGenetics bBioengineering, Stanford University, Stanford cKeck School of Medicine of University of Southern California, Los Angeles, California, USA dDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece eDepartment of Pharmacology, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970941PMC
September 2016

PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics.

Pharmacogenet Genomics 2015 Dec;25(12):622-30

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Anesthesiology dMoffitt Cancer Center, DeBartolo Family Personalized Medicine Institute, Tampa, Florida, USA eGenomics England, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631707PMC
December 2015

PharmGKB summary: Efavirenz pathway, pharmacokinetics.

Pharmacogenet Genomics 2015 Jul;25(7):363-76

Departments of aGenetics bBioengineering, School of Medicine, Stanford University, Stanford, California, USA cDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461466PMC
July 2015

PharmGKB summary: very important pharmacogene information for CFTR.

Pharmacogenet Genomics 2015 Mar;25(3):149-56

Departments of aGenetics, Stanford School of Medicine bBioengineering, Stanford University, Stanford, California cDivision of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center dDepartment of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336773PMC
March 2015

PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics.

Pharmacogenet Genomics 2014 Sep;24(9):464-76

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cACOS for Research, Department of Veterans Affairs Medical Center Departments of dMedicine ePharmacology/Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/FPC.0000000000000058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122637PMC
September 2014

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.

Pharmacogenet Genomics 2014 Aug;24(8):409-25

Departments of aGenetics bBioengineering, Stanford University, Palo Alto, California cDepartment of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville, Kentucky, USA dDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece eDepartment of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109976PMC
August 2014

PharmGKB summary: methylene blue pathway.

Pharmacogenet Genomics 2013 Sep;23(9):498-508

Department of Genetics, Stanford University, Palo Alto, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e32836498f4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091817PMC
September 2013

PharmGKB summary: caffeine pathway.

Pharmacogenet Genomics 2012 May;22(5):389-95

Department of Genetics, Stanford University Medical Center, Stanford, California 94305-5120, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e3283505d5eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381939PMC
May 2012

CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3.

J Leukoc Biol 2008 Apr 3;83(4):875-82. Epub 2008 Jan 3.

Leukocyte Biology Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, South Kensington Campus, London SW7 2AZ, UK. j

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.1006645DOI Listing
April 2008